1. Home
  2. LXU vs PRTC Comparison

LXU vs PRTC Comparison

Compare LXU & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXU
  • PRTC
  • Stock Information
  • Founded
  • LXU 1968
  • PRTC 2015
  • Country
  • LXU United States
  • PRTC United States
  • Employees
  • LXU N/A
  • PRTC N/A
  • Industry
  • LXU Major Chemicals
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXU Industrials
  • PRTC Health Care
  • Exchange
  • LXU Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • LXU 545.6M
  • PRTC 439.8M
  • IPO Year
  • LXU 1969
  • PRTC N/A
  • Fundamental
  • Price
  • LXU $8.22
  • PRTC N/A
  • Analyst Decision
  • LXU Strong Buy
  • PRTC Buy
  • Analyst Count
  • LXU 3
  • PRTC 1
  • Target Price
  • LXU $9.67
  • PRTC $45.00
  • AVG Volume (30 Days)
  • LXU 489.6K
  • PRTC 5.9K
  • Earning Date
  • LXU 07-30-2025
  • PRTC 08-27-2025
  • Dividend Yield
  • LXU N/A
  • PRTC N/A
  • EPS Growth
  • LXU N/A
  • PRTC N/A
  • EPS
  • LXU N/A
  • PRTC 0.21
  • Revenue
  • LXU $527,628,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • LXU $8.50
  • PRTC $35.98
  • Revenue Next Year
  • LXU $1.09
  • PRTC $115.38
  • P/E Ratio
  • LXU N/A
  • PRTC $7.88
  • Revenue Growth
  • LXU N/A
  • PRTC 44.98
  • 52 Week Low
  • LXU $4.88
  • PRTC $13.30
  • 52 Week High
  • LXU $10.40
  • PRTC $25.00
  • Technical
  • Relative Strength Index (RSI)
  • LXU 57.95
  • PRTC 51.10
  • Support Level
  • LXU $7.72
  • PRTC $17.09
  • Resistance Level
  • LXU $8.21
  • PRTC $18.40
  • Average True Range (ATR)
  • LXU 0.31
  • PRTC 0.45
  • MACD
  • LXU -0.05
  • PRTC -0.10
  • Stochastic Oscillator
  • LXU 44.60
  • PRTC 48.55

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: